))
Ep. 59 - Derek Lowe Unplugged: AI; Biosecure; FDA, Abortion & SCOTUS; and more
Manage episode 418586608 series 3571902
Content provided by BioCentury. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioCentury or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
“I’m a short-term pessimist and a long-term optimist” about the potential for AI to transform drug development, Derek Lowe, author of the In the Pipeline blog, told BioCentury Washington Editor Steve Usdin on the latest BioCentury Show. Lowe's skepticism about claims that AI will rapidly transform the field is driven by a belief that the “problems that we have in the drug industry that we want to solve are almost inversely proportional to the ability of AI to solve them." Lowe also discussed the Biosecure Act and U.S. reliance on Chinese contract manufacturing and development organizations; talked about why he hopes and believes the Supreme Court will rule for FDA in litigation over the abortion drug mifepristone; and explained his view that approval of Aduhelm to treat Alzheimer’s disease was one of FDA’s worst decisions
View full story: https://www.biocentury.com/article/652427
#biotech #biopharma #pharma #lifescience #DrugDiscovery
00:00 - Intro
01:04 - Lowe’s Blog
04:42 - Biosecure Act
09:04 - AI & Drug Discovery
16:46 - FDA, The Abortion Drug, & Aduhelm
Chapters
1. Ep. 59 - Derek Lowe Unplugged: AI; Biosecure; FDA, Abortion & SCOTUS; and more (00:00:00)
2. Lowe’s Blog (00:01:04)
3. Biosecure Act (00:04:42)
4. AI & Drug Discovery (00:09:04)
5. FDA, The Abortion Drug, & Aduhelm (00:16:46)
6. Lessons from COVID (00:21:18)
21 episodes
Share
